Avak Kahvejian
InvestorFounderGeneral Partner at Flagship Pioneering · Co-founder, Chairman at ProFound Therapeutics · Founding Team; Founding CEO at Etiome · Chairman (Founder / founding CEO) at Abiologics
Cambridge, Massachusetts
Writes $500K – $15M checks · typically $7M
Find your path to Avak
134 people in our graph share verified history with Avak — schools, employers, funds. One of them is your warm intro.
About
Avak Kahvejian, a venture investor who often serves as founding CEO of biotechs he helps create, leverages Helicos single-molecule sequencing experience to build programmable medicine platforms via internal company creation.
Invests in
AgTechAI & Machine LearningBiotechClimate TechFoodTechHealthtech
Co-founder, Chairman at ProFound Therapeutics
Intro paths
In turn, Avak can intro founders to ProFound Therapeutics's investors below.
ProFound Therapeutics's investors · 2
Co-founders at ProFound Therapeutics
Founding Team; Founding CEO at Etiome
Intro paths
In turn, Avak can intro founders to Etiome's investors below.
Etiome's investors · 1
Co-founders at Etiome

Chairman (Founder / founding CEO) at Abiologics
Intro paths
In turn, Avak can intro founders to Abiologics's investors below.
Abiologics's investors · 1
Co-founders at Abiologics
Experience
- Flagship PioneeringPresident, Flagship Labscurrent2026 — presentCambridge, Massachusetts, United States
- Flagship PioneeringGeneral Partnercurrent2020 — present
- Flagship PioneeringPartner2011 — 2020Cambridge, MA
- EtiomeBoard Membercurrent2024 — presentCambridge, Massachusetts, United States
- EtiomeFounding CEO2024 — 2026
- Ampersand BiomedicinesChairman of the Boardcurrent2021 — presentBoston, Massachusetts, United States
- Ampersand BiomedicinesFounding CEO2021 — 2023Boston, Massachusetts, United States
- ProFound TherapeuticsChairman of the Boardcurrent2020 — present
- ProFound TherapeuticsFounding CEO2020 — 2023Cambridge, Massachusetts, United States
- CellarityBoard Membercurrent2017 — present
- CellarityFounding CEO2017 — 2020
- Ring TherapeuticsChairman of the Boardcurrent2021 — presentCambridge, Massachusetts, United States
- Ring TherapeuticsBoard Membercurrent2017 — present
- Ring TherapeuticsFounding CEO2017 — 2020
- AbiologicsFounding CEO and Board Member2021 — 2026Boston, Massachusetts, United States
- Sail BiomedicinesBoard Member2017 — 2025
- Sail BiomedicinesFounding CEO2017 — 2020Cambridge, Massachusetts, United States
- Generate Biomedicines, Inc.Board Member2018 — 2021
- Generate Biomedicines, Inc.Founding Co-CEO2017 — 2021Cambridge, Massachusetts, United States
- Cygnal TherapeuticsBoard Member2017 — 2021
- Cygnal TherapeuticsChief Innovation Officer2019 — 2020
- Cygnal TherapeuticsFounding President & CEO2017 — 2019Cambridge, Massachusetts
- Codiak BioSciencesMember Board Of Directors2017 — 2019Cambridge, MA
- Codiak BioSciencesBoard Observer2015 — 2017
- Rubius TherapeuticsChief Innovation Officer2017 — 2018Cambridge, Massachusetts
- Rubius TherapeuticsFounding President & CEO2013 — 2017Cambridge, MA
- Liberate DiagnosticsVice President, Business Development2011Cambridge, MA
- Helicos BioSciencesVice President, Business Development2010 — 2011
- Helicos BioSciencesDirector of Business Development2009 — 2010
- Helicos BioSciencesProduct Manager2004 — 2009
- PerSeptive BioSystemsProduct Evaluation Lab Associate1996
Skills & more
+12 more
SalesProduct ManagementProject ManagementCross-functional Team LeadershipEntrepreneurshipBioinformaticsBiopharmaceuticalsDNAMolecular DiagnosticsSequencingLife SciencesResearch and Development (R&D)Languages Armenian · English · French
From Avak's professional profile.
Colleagues at Flagship Pioneering
Network1
Investors connected to Avak in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Avak Kahvejian?
- Avak Kahvejian, a venture investor who often serves as founding CEO of biotechs he helps create, leverages Helicos single-molecule sequencing experience to build programmable medicine platforms via internal company creation.
- Where does Avak Kahvejian work?
- Avak Kahvejian is Chairman (Founder / founding CEO) of Abiologics and General Partner at Flagship Pioneering and Co-founder, Chairman at ProFound Therapeutics and Founding Team; Founding CEO at Etiome.
- What does Avak Kahvejian invest in?
- Avak Kahvejian invests in AgTech, AI & Machine Learning, Biotech, Climate Tech, FoodTech, Healthtech.
- What check size does Avak Kahvejian write?
- Avak Kahvejian typically writes checks of $500K – $15M.
- What companies did Avak Kahvejian found?
- Avak Kahvejian founded Abiologics, Etiome, ProFound Therapeutics.
- Where did Avak Kahvejian go to school?
- Avak Kahvejian studied at McGill University (Ph.D., Biochemistry); McGill University (B.Sc., Biochemistry); Marianopolis College (DEC, General Sciences).
Founder mafias
McGill University mafia208
Also came through, then founded or led a company.
+ 201 more
Flagship Pioneering mafia21
Also came through, then founded or led a company.
+ 14 more
Marianopolis College mafia14
Also came through, then founded or led a company.
+ 7 more
Cellarity mafia4
Also came through, then founded or led a company.
Codiakbio mafia4
Also came through, then founded or led a company.
Same school
Also attended McGill University651
+ 645 more
Also attended Marianopolis College33
+ 27 more
Also attended Collège Stanislas7
+ 1 more
Shared employers
Also worked at Flagship Pioneering88
+ 82 more
Also worked at Etiome1
Also worked at Cellarity7
+ 1 more















































)



